Correlation Analysis of NAMPT rs61330082 Polymorphism in Type 2 Diabetes Mellitus Combined with Hypertension
DOI: https://doi.org/10.2147/dmso.s458416
2024-04-19
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Chao Zuo, 1 Yi Liu, 1 Ziqiang Wang, 2 Jing Cheng, 1 Dongli Yang, 1 Huasong Gong, 1 Yu Wang, 3 Yongchao Qiao 1 1 Department of Clinical Laboratory, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, People's Republic of China; 2 Research Center of Clinical Laboratory Science, Bengbu Medical College, Bengbu, Anhui, People's Republic of China; 3 Department of Geriatrics, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, People's Republic of China Correspondence: Yongchao Qiao, Department of Clinical Laboratory, Affiliated Hospital of Guilin Medical University, Le Qun Road 15, Guilin, Guangxi, 541001, People's Republic of China, Email Yu Wang, Department of Geriatrics, Affiliated Hospital of Guilin Medical University, Le Qun Road 15, Guilin, Guangxi, 541001, People's Republic of China, Tel +86 773 2822730, Email Introduction: This study aimed to investigate the association of Nicotinamide phosphoribosyl transferase (NAMPT) rs61330082 polymorphism with co-morbid hypertension (HTN) and the progression of hypertension in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: A total of 453 T2DM patients were genotyped for the polymorphism of rs61330082 using SNP-scan high-throughput technology. These patients were divided into T2DM group (261 patients) and T2DM combined with hypertension group (T2MH, 192 patients). The T2MH group was further categorized into Grade I, Grade II, and Grade III based on the results of the Hypertension Grade Score. Peripheral blood plasma urea, plasma creatinine, renin-angiotensin system (RAS) indexes, and lipid biochemistry indexes were measured in patients and analyzed in relation to NAMTP polymorphisms. Results: We found that the presence of the NAMPT rs61330082-AA genotype was associated with a significantly increased risk of developing higher-grade hypertension in patients with T2MH. In addition, the A allele of the NAMPT rs61330082 gene displayed more associated in developing a higher grade of hypertension compared to the G allele. Also, the level of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) increased with hypertension grade in the NAMPT rs61330082-GG genotype. Conclusion: NAMPT rs61330082 polymorphism was significantly associated with the progression of hypertension grade in T2MH patients and also affected plasma creatinine and LDL-c levels. Keywords: NAMPT, polymorphism, T2DM, hypertension classification Globally, the number of people with diabetes has increased exponentially over the past three decades and 90% of them have type 2 diabetes (T2DM). 1 The prevalence of diabetes mellitus in China increased from 10.9% to 12.4% between 2013 and 2018, 2 with approximately 60% of T2DM patients having comorbid hypertension, 3 and the combination of diabetes mellitus and hypertension produces a synergistic effect that significantly increases the risk of occurrence and progression of macrovascular and microvascular complications. 4 The prevalence is increasing in all age groups, but the trend is more severe in the younger age groups and there is substantial evidence of a strong correlation between morbidity and mortality from complications such as hypertension and cardiovascular disease. 5,6 Insulin resistance is a common pathway in the development of T2DM and hypertensive disease. 7 Nicotinamide phosphoribosyl transferase (NAMPT), an adipokine secreted primarily by macrophages and adipocytes, also known as visfatin and pre-B cell colony-enhancing factor, is considered to be an insulin mimetic factor and a potential regulator in inflammatory and immune processes, 8,9 and contributed to the onset of insulin resistance, a typical characteristic of T2DM. 10 Then, the NAMPT gene is located between human chromosome 7q22.2 and q31.33 and contains 10 introns and 11 exons, 11 which was found to be associated with insulin resistance syndrome-related phenotypes in nondiabetic Mexican-Americans. 12 Many studies have reported the association between NAMPT gene polymorphisms and hypertension 13,14 and its resulting cardiovascular diseases 15,16 and diabetes, 17,18 however, the conclusions are inconsistent. There are also no studies analyzing its association with T2DM combined with hypertension. Therefore, we explored the association of NAMPT gene polymorphisms with Chinese patients with T2DM combined with hypertension and their hypertension grading and analyzed its relationship with lipids. All subjects were 453 patients with T2DM diagnosed between September 2021 and January 2022 at Guilin Medical University -Abstract Truncated-
endocrinology & metabolism